Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 10, 2015
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome InhibitorsDenise Toscani, Carla Palumbo, Benedetta Dalla Palma, et al.
Cells|September 23, 2015
NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma ModelAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
International Journal of Hematology|October 5, 2016
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?Valentina Marchica, Fabrizio Accardi, Paola Storti, et al.
Recenti Progressi in Medicina|January 22, 2026
[Malignant Wound Assessment Tool-Clinical version: Italian translation and content and face validation for the assessment of malignant cutaneous wounds.]Gabriele Cremona, Fiorella Bersanetti, Francesca Costa, et al.
Oncotarget|September 17, 2017
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formationFederica Costa, Denise Toscani, Antonella Chillemi, et al.
Haematologica|January 7, 2017
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclastsMarina Bolzoni, Domenica Ronchetti, Paola Storti, et al.
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
Pageof 3